Hepatology

A recent study offers new insight into the prevalence and implications of steatotic liver disease in older adults.

A new retrospective study has proposed a predictive model for cirrhosis and hepatocellular carcinoma in individuals with haemochromatosis.

The study raises important concerns about the long-term mental health of individuals with resolved HBV infection.

Timely public health policies targeting key metabolic conditions can reduce the global burden of MASLD.

The findings suggest that lifestyle factors beyond alcohol, such as diet and physical inactivity, may play a more substantial role in fatty liver development.

The study concludes that ED-based opt-out testing is both effective and acceptable in detecting hepatitis.

The study concludes that decentralised and person-centred hepatitis screening is effective and essential.

A new study sheds light on the role of CD4 T cell autophagy, a cellular recycling process, in the progression of liver fibrosis.

This research highlights the importance of innovative blood-based diagnostics in bridging current gaps.

Notably, the study found that bariatric surgery was cost-effective based on the incremental cost-effectiveness ratio.

A nationwide retrospective cohort study was conducted to assess the impact of population size on waiting list outcomes for patients with acute liver failure.

Discover a new study that combined selective internal radiation therapy with nivolumab for patients with HCC.

Compared to controls, the rhTPO group experienced fewer bleeding events and a lower mortality rate.

A recent study explored the combined impact of oral nutritional supplementation and probiotics on gut microbiota and liver function.

A recent study highlighted the potential benefits of digital health interventions in improving physical recovery for patients with primary liver cancer.

A key finding was the significant increase in serum UDCA levels in the aerobic group.

This recent study assessed the potential of urinary biomarkers to predict patient mortality in cirrhotic individuals.

Discover new research on how liver disease affects circadian rhythms. Learn more.

While effective therapies exist, challenges remain in managing acute liver failure, where transplantation may be life-saving.

CT could also help assess fatty liver using advanced tools such as 3D automated volumetric analysis.

Recent studies have identified a gene signature known as the senescent hepatocyte gene signature that tracks with MASLD progression.

The “wine mum” culture, which normalises excessive alcohol consumption, further perpetuates harmful drinking behaviours.

Discover a project that designed EchoNet-Liver, a deep-learning computer-vision pipeline to cirrhosis and steatotic liver disease.

A recent study analysed CT imaging findings from 48 pathologically confirmed cases of hepatic CE.

A Phase 2 clinical trial finds that ALT flares are common in hepatitis D patients treated with pegylated interferon-alpha, but pose no safety risk, and may even signal better viral response.

This study aimed to explore anxiety trends among HCV-infected people who inject drugs.

A recent first-in-human gene therapy trial using DTX401 has shown promising results in improving glucose homeostasis.

The findings demonstrated a clear reduction in psychological distress and sleep disturbances among patients who received targeted nursing care.

An ideal ventilation support mode should enhance patient-ventilator interaction while minimising asynchronies and haemodynamic disturbances.

Chitosan, a dietary fibre derived from chitin in fungi, mushrooms, and crustaceans, has shown potential for weight and fat reduction.

Methods like preoperative time-outs improve communication but can lead to information overload.

Recent developments in machine learning have allowed researchers to reconstruct long-term disease patterns.

A large-scale study finds that the hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic hepatitis B.

The connection between Type 2 diabetes and NAFLD is primarily driven by insulin resistance, which increases free fatty acid levels.

Time-restricted feeding (TRF), limits food intake to a set daily window, such as the 16:8 model.

Mitochondrial impairment is a key factor in MASLD and MASH development, affecting oxidative capacity and energy homeostasis.

Overall, the global hepatitis A landscape has evolved due to shifting transmission routes and pandemic responses.

A clinical trial found that pomegranate peel extract improves liver enzymes, triglycerides, and inflammation markers in NAFLD patients.

These findings challenge existing practices in some institutions that administer prophylactic anticoagulation after liver transplantation.

The study suggests that rencofilstat 225mg/d improves both liver function and portal-systemic shunting in patients with MASH.